The United Laboratories International Holdings Statistics
Want to see HK:3933 full AI Analyst Report?
The United Laboratories International Holdings (3933) Stock Statistics & Valuation Metrics
Total Valuation
The United Laboratories International Holdings has a market cap or net worth of HKD 14.22B. The enterprise value is HKD 10.04B.
- Market Cap
- HKD 14.22B
- Enterprise Value
- HKD 10.04B
Share Statistics
The United Laboratories International Holdings has 1,970,276,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,970,276,500
- Owned by Insiders
- ―
- Owned by Institutions
- 8.23%
Financial Efficiency
The United Laboratories International Holdings’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.15%.
- Return on Equity (ROE)
- 0.12
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 8.15%
- Return on Capital Employed (ROCE)
- 0.11
- Revenue Per Employee
- 733.92K
- Profits Per Employee
- 115.88K
- Employee Count
- 18,000
- Asset Turnover
- 0.43
- Inventory Turnover
- 3.25
Valuation Ratios
The current PE Ratio of The United Laboratories International Holdings is 21.95. The United Laboratories International Holdings’s PEG ratio is -0.26.
- PE Ratio
- 21.95
- PS Ratio
- 1.01
- PB Ratio
- 0.70
- Price to FCF
- 50.82
- Price to Operating Cash Flow
- 6.59
- PEG Ratio
- -0.26
Income Statement
In the last 12 months, The United Laboratories International Holdings had revenue of 13.21B and earned 2.09B in profits. Earnings per share was 1.11.
- Revenue
- 13.21B
- Gross Profit
- 5.51B
- Operating Income
- 2.27B
- Pretax Income
- 2.53B
- Net Income
- 2.09B
- EBITDA
- 2.87B
- Earnings Per Share (EPS)
- 1.11
Cash Flow
In the last 12 months, operating cash flow was 1.83B and capital expenditures -1.59B, giving a free cash flow of 236.66M billion.
- Operating Cash Flow
- 1.83B
- Free Cash Flow
- 236.66M
- Free Cash Flow per Share
- 0.12
Dividends & Yields
The United Laboratories International Holdings pays an annual dividend of HKD 0.30, resulting in a dividend yield of 6.57%
- Dividend Per Share
- HKD 0.30
- Dividend Yield
- 6.57%
- Payout Ratio
- 35.48%
- Free Cash Flow Yield
- 1.98%
- Earnings Yield
- 4.50%
Stock Price Statistics
- Beta
- 1.08
- 52-Week Price Change
- -40.22%
- 50-Day Moving Average
- 7.54
- 200-Day Moving Average
- 9.04
- Relative Strength Index (RSI)
- 42.68
- Average Volume (3m)
- 5.64M
Important Dates
The United Laboratories International Holdings upcoming earnings date is Mar 30, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 31, 2026
- Next Earnings Date
- Mar 30, 2027
- Ex-Dividend Date
- Jul 07, 2026
Financial Position
The United Laboratories International Holdings as a current ratio of 1.83, with Debt / Equity ratio of 28.70%
- Current Ratio
- 1.83
- Quick Ratio
- 1.60
- Debt to Market Cap
- 0.25
- Net Debt to EBITDA
- -2.18
- Interest Coverage Ratio
- 32.58
Taxes
In the past 12 months, The United Laboratories International Holdings has paid 446.87M in taxes.
- Income Tax
- 446.87M
- Effective Tax Rate
- 0.18
Enterprise Valuation
The United Laboratories International Holdings EV to EBITDA ratio is 4.83, with an EV/FCF ratio of 26.15.
- EV to Sales
- 0.52
- EV to EBITDA
- 4.83
- EV to Free Cash Flow
- 26.15
- EV to Operating Cash Flow
- 3.39
Balance Sheet
The United Laboratories International Holdings has HKD 11.73B in cash and marketable securities with HKD 5.95B in debt, giving a net cash position of HKD 5.78B billion.
- Cash & Marketable Securities
- HKD 11.73B
- Total Debt
- HKD 5.95B
- Net Cash
- HKD 5.78B
- Net Cash Per Share
- HKD 2.93
- Tangible Book Value Per Share
- HKD 8.61
Margins
Gross margin is 31.28%, with operating margin of 4.64%, and net profit margin of 4.55%.
- Gross Margin
- 31.28%
- Operating Margin
- 4.64%
- Pretax Margin
- 4.84%
- Net Profit Margin
- 4.55%
- EBITDA Margin
- 10.80%
- EBIT Margin
- 4.48%
Analyst Forecast
The average price target for The United Laboratories International Holdings is HKD 10.85, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- HKD 10.85
- Price Target Upside
- 51.78% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- -12.86%
- EPS Growth Forecast
- -83.10%
Scores
- Smart Score
- 3
- AI Score
- 58.2

